Effects of L-carnitine Therapy on the Heart of Maintenance Hemodialysis Patients
Launched by THE FIRST AFFILIATED HOSPITAL OF ZHEJIANG CHINESE MEDICAL UNIVERSITY · Jan 3, 2023
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Maintenance hemodialysis patients;
- • 18 years\<80 years;
- • Have clear consciousness and independent behavior ability;
- • Before dialysis, the total carnitine concentration was less than 40 umol/L, or the free carnitine concentration was less than 35 umol/L.
- Exclusion Criteria:
- • Acute cardiovascular and cerebrovascular diseases occurred within 1 month;
- • Infectious diseases occurred within 1 month; Treatment with glucocorticoid or immunosuppressant;
- • Patients who have used L-carnitine within 2 weeks.
- • Hematological system tumor or tumor;
About The First Affiliated Hospital Of Zhejiang Chinese Medical University
The First Affiliated Hospital of Zhejiang Chinese Medical University is a leading institution in clinical research and medical education, renowned for its commitment to advancing healthcare through innovative research initiatives. As a prominent teaching hospital, it integrates cutting-edge medical practices with a strong emphasis on patient care and community health. The hospital is dedicated to fostering collaborative clinical trials that aim to improve therapeutic outcomes and enhance the understanding of various medical conditions. Its experienced team of researchers and healthcare professionals is focused on conducting rigorous and ethical studies, contributing significantly to the global medical community and the advancement of evidence-based medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hangzhou, Zhejiang, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials